Home / Solutions / Customers

Customer outcomes

Autonomous biologics operations for the teams accountable for every batch.

Bioseon serves CDMOs and biopharma manufacturers across mAbs, vaccines, GLP-1 and recombinant proteins, and cell and gene therapy. References below are anonymized and aspirational for an early independent startup.

Trust · Autonomy · Outcomes

Built for operators, MSAT, process science, QA, and site leadership.

Bioseon is proof-driven, auditable, and focused on manufacturing value.

Two customer groups, one operating layer.

CDMOs

Contract development and manufacturing organizations use Bioseon to stabilize customer programs, compress tech transfer, protect suites, and improve reviewer throughput.

  • Multi-customer process variation
  • Capacity and schedule pressure
  • High cost of deviations

Biopharma manufacturers

Biopharma teams use Bioseon to run critical biologics capacity with tighter control, CQA visibility, and auditable execution.

  • Product-specific CQA targets
  • Scale-up and process transfer
  • Inspection-ready operations

Aspirational case study: mAb CDMO stabilizes fed-batch variance.

A global CDMO deploys Bioseon on a CHO mAb production train to sense titer and CQA drift earlier, then guide feed and gas setpoints inside validated envelopes.

  • Shadow mode against prior batches
  • Closed-loop feed recommendations
  • Review-by-exception for deviations
HighTITER CONSISTENCY

Targeting less batch-to-batch variance.

LowerREVIEW BURDEN

Exception-led QA focus.

EarlierRISK SIGNALS

Environmental and process signals fused in one view.

TighterPROCESS WINDOW

Control strategy aligned to live biology.

Aspirational case study: vaccine manufacturer protects a narrow process window.

A vaccine manufacturing team uses Bioseon to monitor contamination risk, viable culture state, and downstream readiness across a sensitive production campaign.

  • Contamination and deviation intelligence
  • PAT and historian data in context
  • Auditable recommendations for operators

Aspirational case study: cell and gene therapy team standardizes patient-batch execution.

For workflows where each batch matters intensely, Bioseon helps teams encode the process playbook, preserve traceability, and coordinate review.

  • Role-based operating guidance
  • Batch record review by exception
  • Action provenance for GMP review
EveryBATCH TRACEABLE

Decisions and actions remain inspection-ready.

LessMANUAL CHASING

QA focuses on the records that need attention.

Measured where manufacturing leaders already care.

TITER AND YIELD

Up. Better control of feed, perfusion, fermentation, and purification.

CONTAMINATION

Down. Earlier warnings before a suite loses time.

DEVIATIONS

Down. Fewer uncontrolled drifts and cleaner records.

REVIEW SPEED

Faster. Batch review by exception, with provenance.

The best process scientist, encoded and auditable.

"Bioseon gives our night shift the same process intuition our senior MSAT team brings during the day, with every recommendation traceable."
VP MSAT · Global CDMO, anonymized illustration

Autonomy that works inside GMP reality.

"We are not looking for another dashboard. We need a layer that can sense, decide, act, and stand up to quality review."
Head of Manufacturing Sciences · Biopharma manufacturer, anonymized illustration

Coverage for the biologics programs driving capacity demand.

mAbs

Fed-batch and perfusion CHO with titer and glycan control needs.

Vaccines

Viral, subunit, and related platforms with contamination sensitivity.

GLP-1 and proteins

Fermentation and recombinant protein capacity with recovery economics.

Cell and gene

Patient-batch traceability and highly orchestrated production flows.

CDMOsBiopharmaMSATQAManufacturing ops

Solutions

See how Bioseon maps to modalities and facility workflows.

Open solutions

Platform

Review the autonomous operations layer from sensing to control.

Open platform

Pricing

Understand line, site, and enterprise pricing options.

Open pricing

Show us the batch problem you want autonomy to solve first.

We will map your modality, train, data sources, and target outcomes.